Table of Contents    
Editorial
 
Relieving hepatic steatosis: Another benefit of dipeptidyl peptidase-4 (DPP4) inhibitors
Zachary Braunstein1, Jixin Zhong2
1Boonshoft School of Medicine, Wright State University, Dayton, Ohio, USA.
2Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Article ID: 100036IJHPDZB2015
doi:10.5348/ijhpd-2015-36-ED-11

Address correspondence to:
Jixin Zhong
MD, PhD, Department of Medicine University of Maryland School of Medicine
20 Penn St., S022; Baltimore, MD 21201
USA
Phone: 410-706-3582
Fax: 410-706-3583

Access full text article on other devices

  Access PDF of article on other devices

[HTML Full Text]   [PDF Full Text] [Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar]

How to cite this article
Braunstein Z, Zhong J. Relieving hepatic steatosis: Another benefit of dipeptidyl peptidase-4 (DPP4) inhibitors. Int J Hepatobiliary Pancreat Dis 2015;5:67–69.


Abstract

No Abstract


[HTML Full Text]   [PDF Full Text]

Author Contributions:
Zachary Braunstein – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Jixin Zhong – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Guarantor of submission
The corresponding author is the guarantor of submission.
Source of support
None
Conflict of interest
Authors declare no conflict of interest.
Copyright
© 2015 Zachary Braunstein et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.